Restricted clinical efficacy of cyclosporin A on rat transient middle cerebral artery occlusion

Life Sciences

Volumn 72, Issue 4-5, 2002, Pages 591-600

  Matsumoto, Shohei ^a   Isshiki, Atsushi ^a   Watanabe, Yasuo ^a   Wieloch, Tadeusz ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cyclosporin A; Focal cerebral ischemia; mtPTP; Neuroprotection

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEEDLE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION; STROKE;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BLOOD-BRAIN BARRIER; BRAIN; COLORING AGENTS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAPERITONEAL; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; TETRAZOLIUM SALTS;

ANIMALIA;

EID: 0037146882     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02267-1     Document Type: Conference Paper

References (27)

1. Albayrak S., Zhao Q., Siesjo B.K., Smith M.L. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury. Acta Neuropathology (Berl). 94:1997;158-163.
2. Alberch J., Perez-Navarro E., Canals J.M. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease. Brain Research Bulletin. 57(6):2002;817-822.
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
4. Begley D.J., Squires L.K., Zlokovic B.V., Mitrovic D.M., Hughes C.C., Revest P.A., Greenwood J. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. Journal of Neurochemistry. 55:1990;1222-1230.
5. Bernareggi A., Rowland M. Physiologic modeling of cyclosporin kinetics in rat and man. Journal of Pharmacokinetics Biopharmacy. 19:1991;21-50.
6. Brenneman D.E., Hauser J., Spong C.Y., Phillips T.M. Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity. Annual New York Academy Science. 921:2000;109-114.
7. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. Journal of Neuroscience. 17:1997;6939-6946.
8. Friberg H., Connern C., Halestrap A.P., Wieloch T. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. Journal of Neurochemistry. 72:1999;2488-2497.
9. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. Journal of Neuroscience. 18:1998;5151-5159.
10. Garcia J.H. The evolution of brain infarcts. A review. Journal of Neuropathology Experimental Neurology. 51:1992;387-393.
11. Kahan B.D. Clinical problems in cyclosporine dosing with reference to clinical pharmacology: case histories and discussion. Transplantation Proceeding. 21:1989;16-40.
12. Khaspekov L., Friberg H., Halestrap A., Viktorov I., Wieloch T. Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. European Journal of Neuroscience. 11:1999;3194-3198.
13. Kuroiwa T., Shibutani M., Okeda R. Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental focal cerebral ischemia. Acta Neuropathology (Berl). 76:1988;62-70.
14. Liu J., Albers M.W., Wandless T.J., Luan S., Alberg D.G., Belshaw P.J., Cohen P., MacKintosh C., Klee C.B., Schreiber S.L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 31:1992;3896-3901.
15. Matsumoto S., Friberg H., Ferrand-Drake M., Wieloch T. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. Journal of Cerebral Blood Flow Metabolism. 19:1999;736-741.
16. McDonald J.W., Goldberg M.P., Gwag B.J., Chi S.I., Choi D.W. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Annual Neurology. 40:1996;750-758.
17. McIntosh T.K., Vink R., Noble L., Yamakami I., Fernyak S., Soares H., Faden A.L. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience. 28:1989;233-244.
18. Memezawa H., Minamisawa H., Smith M.L., Siesjo B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Experimental Brain Research. 89:1992;67-78.
19. Sakata A., Tamai I., Kawazu K., Deguchi Y., Ohnishi T., Saheki A., Tsuji A. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochemical Pharmacology. 48:1994;1989-1992.
20. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
21. Shiga Y., Onodera H., Matsuo Y., Kogure K. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Research. 595:1992;145-148.
22. Uchino H., Elmer E., Uchino K., Li P.A., He Q.P., Smith M.L., Siesjo B.K. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Research. 812:1998;216-226.
23. Wang H.G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T., Franke T.F., Reed J.C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343.
24. Wang X., Li X., Currie R.W., Willette R.N., Barone F.C., Feuerstein G.Z. Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. Journal of Neuroscience Research. 59:2000;238-246.
25. Wieloch T. Mitochondrial involvement in acute neurodegeneration. IUBMB Life. 52:2001;247-254.
26. Yang G.Y., Betz A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 25:1994;1658-1664. [discussion 1664-1655].
27. Zhao Q., Memezawa H., Smith M.L., Siesjo B.K. Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Research. 649:1994;253-259.